TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Heart Failure Events (HFEs)
Endpoint domain: Mortality/survival
Primary endpoint: Volume of local anaesthetic mixture for breakthrough pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bromage Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in fecal microbiota composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain associated with uterine contractions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in quantity of rescue opioids
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Safety of Adoptive Cell Therapy with TILs
Endpoint domain: Adverse events/effects
Primary endpoint: Difference in longitudinal relaxation time (T1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 4-mo PFS in patients with recurrent medulloblastoma
Endpoint domain: Mortality/survival
Primary endpoint: 1-yr OS in patients with newly diagnosed DIPG
Endpoint domain: Mortality/survival
Primary endpoint: 1-yr PFS in patients with newly diagnosed HGG
Endpoint domain: Mortality/survival
Primary endpoint: Follow-Up with Primary Care Provider
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of time with SpO2 within the target range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: normalisation of respiratory status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of ED returns
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Nursing Job Satisfaction Survey (NJSS) Score
Endpoint domain: Life impact
Endpoint subdomain: Job satisfaction
Primary endpoint: Change in Oxford Happiness Questionnaire (OHQ) Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in whole body lean mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of the QDOT Micro System
Endpoint domain: Adverse events/effects
Primary endpoint: Effectiveness of the QDOT Micro System at 12-months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of the QDOT Micro System at 24-months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of the QDOT Micro System at 36-months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with complications
Endpoint domain: Adverse events/effects
Primary endpoint: shoulder pain and impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of dengue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Meibomian Gland Appearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge about hypertension
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adherence to antihypertensive treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement between reference tube size and final BFT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Children Who Consume a Minimum Acceptable Diet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anemia Prevalence of Children
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: CRP to albumin ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Pittsburgh Sleep Quality Index(PSQI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Serum concentrations of FABP2 following short, intense exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum concentrations of LBP following short, intense exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum concentrations of sCD14 following short, intense exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum concentrations of FABP2 following sustained, moderate exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum concentrations of IL-6 following sustained, moderate exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of participants with 3-month SBP control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pain by Visual analogue scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Range of motion of shoulder joint by universal goniometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knowledge of ASD
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: siblings relationship
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: well-being of siblings of ASD
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: AUROC value for predicting positive needle biopsy results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity for predicting positive needle biopsy results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity for predicting positive needle biopsy results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eye malformations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increase in Knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: decrease in depression stigma
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Composite outcome of thromboembolic events and all-cause mortality
Endpoint domain: Mortality/survival
Primary endpoint: IBS-SSS score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fibromyalgia Impact Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence of conversion
Endpoint domain: Adverse events/effects
Primary endpoint: User Mobile Application Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of suctioning leading to deep desaturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Risk stratification in acute coronary syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of completion of at least 4 cycles of oral maintenance therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Program Session Completion Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Data Collection Completion Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of hospital readmissions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of participants on treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Adult patient health-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pediatric patient health-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Adult patient care-partner and pediatric patient parent/care-partner health-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in arrhythmia burden measured by the number of VT events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in arrhythmia burden measured by the number of ICD events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Acute radiation toxicity within the first 90 days
Endpoint domain: Adverse events/effects
Primary endpoint: rate of recurrence leading to reoperation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Background-corrected Maximum Plasma Concentration [Cmax]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Background-corrected Time to the Maximum Concentration [Tmax]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Background-corrected Concentration-time Curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Subjects Experiencing an Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Center for Epidemiologic Studies Depression Scale (CES-D)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Visual Functioning Questionnaire-25 (VFQ-25)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Swing time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric mean titre of neutralizing antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 4-fold increasing rate of neutralizing antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric mean of antibody titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of participants with Treatment Emergent Adverse Events (TEAEs) [SAD]
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants with Treatment Emergent Adverse Events (TEAEs) [MAD]
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum tolerated dose and/or Recommended Phase II Dose (RP2D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution of PET imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: In-hospital major morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blast cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sit to stand test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plank test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: squat jump test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pressure muscle index (PMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Prevalence of elevated eosinophils
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Work Role Functioning Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Significant loci of genetic variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PAS score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Acceptable EEG recording on first attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Ophthalmological Test Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Perception Test Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life (QoL) Assessment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Transcutaneous Bilirubin (TcB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Experience of anticipatory nausea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Worst of anticipatory nausea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of anticipatory nausea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants with a high Genetic Risk Score (GRS) who take action as a result
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Occurrence of serious Treatment-Emergent Adverse Events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of TEAEs leading to permanent withdrawal of IMP
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of Adverse Event(s) of Special Monitoring (AESM)
Endpoint domain: Adverse events/effects
Primary endpoint: Ankylosing Spondylitis Disease Activity score (ASDAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recruitment rate for feasibility and acceptability of Outreach-ER
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of days CGM worn
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of time the CGM is active
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: HIV Medication Adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Area under the plasma concentration time curve from time 0 to the last measurable concentration (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICU all-cause mortality
Endpoint domain: Mortality/survival
Primary endpoint: Change in level of understanding in key survivorship knowledge areas
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Nasal congestion score (NCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serious Adverse Events related to implantation
Endpoint domain: Adverse events/effects
Primary endpoint: Urine Protein to Creatinine Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Annualized total estimated Glomerular Filtration Rate (eGFR) slope
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Intraocular lens axial displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Recurrent Laryngeal nerve injury
Endpoint domain: Adverse events/effects
Primary endpoint: Hemodynamic status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in pain interference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nitrogen Balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: I-FABP Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CNS Objective Response Rate (CNS-ORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: COVID-19 Self-Testing Knowledge, Attitudes, and Practices Questionnaire Score - study initiation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: COVID-19 Self-Testing Knowledge, Attitudes, and Practices Questionnaire Score - study completion
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in DNA-methylation patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PID-5-BF+M questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: LPFS-BF 2.0 questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Attentional bias changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of adherence to the sampling protocol
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Prescription rate of modified default dose for high-risk drugs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Effectiveness of paramedian flap skin incision technique
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Sensitivity and Specificity of Nevisense
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physiological dentin formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intracranial Overall Response Rate (iORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Extracranial Overall Response Rate (eORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in HVA Metabolite Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Insula Activation to Cannabis Cues
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of participants who test positive for bloodstream infection
Endpoint domain: Adverse events/effects
Primary endpoint: NK cells profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Determine the recommended phase II dose (RP2D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Thyroidectomy complications rate
Endpoint domain: Adverse events/effects
Primary endpoint: Mortality after traumatic pelvic ring injuries
Endpoint domain: Mortality/survival
Primary endpoint: 30% improvement in SALT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change From Baseline in 24-hour Mean SBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in gut and oral microbiome profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Preoperative Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Postoperative, In-patient Pain Unpleasantness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reported number of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Meibomian gland imaging (Meibography)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spectral characteristics of resting electroencephalography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Spatial distribution of electroencephalography rhythms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Functional connectivity measures in standard frequency bands
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mu rhythm desynchronization within the motor imagery paradigm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Middle Cerebral Artery Velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cerebrovascular Resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cerebrovascular Conductance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cerebrovascular Pulsatility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Dynamic Cerebral Autoregulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Caries Experience
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUROC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum high sensitivity c reactive protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Baseline eGFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Baseline uACR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Baseline serum creatinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Characteristics of the newborn
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PFS rate at 24 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change Scores of 20-Item Short Form Survey
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change Scores of Goal Attainment Scaling
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: The Short Assessment of Health Literacy-English (SAHL-E)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Average concentration (Cavg) of single-dose IV POS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum concentration (Cmax) of single-dose IV POS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve from dosing to 24 hours postdose (AUC0-24) of single-dose IV POS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insomnia Severity Scale (ISI) scores
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Quality of Recovery scale (QoR-15) scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean Change in CAPS-5 Total Symptom Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of dental wear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of gingival recession
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hand relaxation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes